Patent ID: 11964971
Assignee: SKYHAWK THERAPEUTICS, INC.
Field: Organic fine chemistry (Chemistry)
Classification: CPC C  A | IPC C

Claim 7:
8. The compound of claim 1, or a pharmaceutically acceptable salt or pharmaceutically acceptable solvate thereof, wherein:
ring Q is, , wherein each RQ is independently selected from hydrogen, deuterium, —F, —Cl, —CN, —OH, —CH3, —CH2CH3, -CH2CHdCH3, —CH(CH3)2, —CF3, —OCH3, —OCH2CH3, —CH2OCH3, —OCH2CH2CH3, and —OCH(CH3)2; and ring P is substituted or unsubstituted aryl or substituted or unsubstituted heteroaryl.